Myeloid-derived suppressor cells as a therapeutic target in sepsis

Andressa Assis Teixeira, Maria Vitória Stoffel Damasceno Boquimpani, Desyree de Farias Gonçalves, Valéria de Lima Kaminski · 2026

Read Myeloid-derived suppressor cells as a therapeutic target in sepsis by Andressa Assis Teixeira, Maria Vitória Stoffel Damasceno Boquimpani, Desyree de Farias Gonçalves, Valéria de Lima Kaminski (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7212359767.txt.

Description

Andressa Assis Teixeira leads a team on a cell group that may hold a key to sepsis care. Sepsis is the body's wild swing at a germ: first a storm of attack, then a deep hush of the guard. The cells at the core are myeloid-derived suppressor cells. They curb harm to flesh, yet they can lock the guard in that hush. The team read past trials to weigh drugs that aim at these cells.

Fast growth of the cells early in sepsis, the work shows, tracks with poor ends and more deaths. A web of gene switches and small RNA bits runs their growth. To tame the cells, then, could free the guard to fight the germ once more. The risk is the flip side: loose too much, and the first storm may rage. The review maps that tight line for those who build new care.

Catalog record

CREATORAndressa Assis Teixeira, Maria Vitória Stoffel Damasceno Boquimpani, Desyree de Farias Gonçalves, Valéria de Lima Kaminski
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Research Society and Development

Source: https://doi.org/10.33448/rsd-v15i9.51673

Browse the full library · About the Tower of Babel